{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:58:05Z","timestamp":1770454685861,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.03.044","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T16:24:08Z","timestamp":1586622248000},"page":"3854-3861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone"],"prefix":"10.1016","volume":"38","author":[{"given":"Mohamed F.","family":"Jalloh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca E.","family":"Bunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Redd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia A.","family":"Nur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zangin","family":"Zeebari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Mia","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Nordenstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.044_b0005","unstructured":"U.S. Centers Disease Control and Prevention. Years of Ebola Virus Disease outbreaks; 2018. Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html."},{"issue":"13","key":"10.1016\/j.vaccine.2020.03.044_b0010","doi-asserted-by":"crossref","DOI":"10.3201\/eid2313.170898","article-title":"Contributions of the US centers for disease control and prevention in implementing the global health security Agenda in 17 partner countries","volume":"23","author":"Fitzmaurice","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2020.03.044_b0015","doi-asserted-by":"crossref","DOI":"10.3201\/eid2313.170727","article-title":"Ebola response impact on public health programs, West Africa, 2014-2017","volume":"23","author":"Marston","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"9980","key":"10.1016\/j.vaccine.2020.03.044_b0020","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(15)60858-3","article-title":"Global health security: the wider lessons from the west African Ebola virus disease epidemic","volume":"385","author":"Heymann","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.044_b0025","unstructured":"World Health Organization. Ebola vaccines, therapies, and diagnostics; 2015. Available from: https:\/\/www.who.int\/medicines\/emp_ebola_q_as\/en\/."},{"issue":"48","key":"10.1016\/j.vaccine.2020.03.044_b0030","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1016\/j.vaccine.2017.08.058","article-title":"Considerations for use of Ebola vaccine during an emergency response","volume":"37","author":"Walldorf","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.044_b0035","unstructured":"World Health Organization. Guinea Ring Vaccination trial extended to Sierra Leone to vaccinate contacts of new Ebola case; 2015. Available from: https:\/\/www.who.int\/news-room\/detail\/31-08-2015-guinea-ring-vaccination-trial-extended-to-sierra-leone-to-vaccinate-contacts-of-new-ebola-case."},{"issue":"11","key":"10.1016\/j.vaccine.2020.03.044_b0040","article-title":"Containing Ebola at the source with ring vaccination","volume":"10","author":"Merler","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2020.03.044_b0045","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2019.03.004","article-title":"Ebola epidemic in war-torn Democratic Republic of Congo, 2018: acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine","volume":"37","author":"Kasereka","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.03.044_b0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S1473-3099(17)30541-8","article-title":"Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report","volume":"17","author":"Gsell","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.044_b0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.conctc.2016.06.008","article-title":"Beating the odds: successful establishment of a phase II\/III clinical research trial in resource-poor liberia during the largest-ever ebola outbreak","volume":"4","author":"Doe-Anderson","year":"2016","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.044_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1740774515621037","article-title":"Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: design, procedures, and challenges","volume":"13","author":"Kennedy","year":"2016","journal-title":"Clin Trials"},{"issue":"10068","key":"10.1016\/j.vaccine.2020.03.044_b0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.044_b0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.15585\/mmwr.su6503a14","article-title":"Implementing an Ebola vaccine study - Sierra Leone","volume":"65","author":"Widdowson","year":"2016","journal-title":"MMWR Suppl"},{"issue":"10069","key":"10.1016\/j.vaccine.2020.03.044_b0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2020.03.044_b0080","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/infdis\/jiy020","article-title":"The Sierra Leone trial to introduce a vaccine against Ebola: an evaluation of rVSVG-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak","volume":"217","author":"Samai","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.044_b0085","unstructured":"World Health Organization. Major milestone for WHO-supported Ebola vaccine; 2019 [cited 2019 November]. Available from: https:\/\/www.who.int\/news-room\/detail\/18-10-2019-major-milestone-for-who-supported-ebola-vaccine."},{"key":"10.1016\/j.vaccine.2020.03.044_b0090","unstructured":"U.S. Food and Drug Administration. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response; 2019. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/first-fda-approved-vaccine-prevention-ebola-virus-disease-marking-critical-milestone-public-health."},{"issue":"15","key":"10.1016\/j.vaccine.2020.03.044_b0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.vaccine.2016.02.046","article-title":"Knowledge and attitudes about Ebola vaccine among the general population in Sierra Leone","volume":"34","author":"Huo","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.03.044_b0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2018.12.060","article-title":"Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone","volume":"37","author":"Jendrossek","year":"2019","journal-title":"Vaccine."},{"issue":"49 Pt B","key":"10.1016\/j.vaccine.2020.03.044_b0105","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1016\/j.vaccine.2017.06.026","article-title":"Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: results of a national household survey","volume":"35","author":"Irwin","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.044_b0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(19)30063-5","article-title":"Institutional trust and misinformation in the response to the 2018\u201319 Ebola outbreak in North Kivu, DR Congo: a population-based survey","volume":"19","author":"Vinck","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.044_b0115","article-title":"Ebola in Sierra Leone and DRC: lessons learnt","volume":"366","author":"Kardas-Nelson","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.044_b0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.vaccine.2019.11.056","article-title":"Words matter: vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination","volume":"38","author":"Dudley","year":"2020","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2020.03.044_b0125","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.vaccine.2017.04.056","article-title":"Efforts to monitor Global progress on individual and community demand for immunization: development of definitions and indicators for the Global Vaccine Action Plan Strategic Objective 2","volume":"35","author":"Hickler","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.044_b0130","unstructured":"Glanz KR, Barbara KR, Viswanath K. Health beahvior: theory, research, and practice, 5th ed., San Francisco, California: Jossey-Bass; 2015 July 2015. 512 p."},{"key":"10.1016\/j.vaccine.2020.03.044_b0135","unstructured":"FOCUS1000. Ebola KAP-3 Preliminary Findings; 2014. Available from: http:\/\/focus1000.org\/index.php\/downloads-resources\/download\/4-ebola-kap-study\/25-ebola-kap-3-presentation."},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.044_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000285","article-title":"National survey of Ebola-related knowledge, attitudes and practices before the outbreak peak in Sierra Leone: August 2014","volume":"2","author":"Jalloh","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2020.03.044_b0145","series-title":"Sierra Leone 2004 population and housing census","author":"Government of Sierra Leone","year":"2004"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.044_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154997","article-title":"Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural Malawi: a population cohort study","volume":"11","author":"Mvula","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.044_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ypmed.2015.12.018","article-title":"Predictors of influenza vaccine uptake during the 2009\/10 influenza A H1N1v ('swine flu') pandemic: results from five national surveys in the United Kingdom","volume":"84","author":"Han","year":"2016","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.044_b0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015845","article-title":"Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey","volume":"7","author":"Ochu","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2020.03.044_b0165","series-title":"Exploratory and confirmatory factor analysis: understanding concepts and applications","author":"Thompson","year":"2004"},{"key":"10.1016\/j.vaccine.2020.03.044_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2017.01.013","article-title":"Spearman-Brown prophecy formula and Cronbach's alpha: different faces of reliability and opportunities for new applications","volume":"85","author":"de Vet","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.03.044_b0175","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.vaccine.2019.01.046","article-title":"Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014\u20132015 Ebola outbreak in Sierra Leone","volume":"37","author":"Jalloh","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.044_b0180","article-title":"Acceptability and willingness-to-pay for a hypothetical Ebola virus vaccine in Nigeria","volume":"9","author":"Ughasoro","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2020.03.044_b0185","series-title":"Global vaccine action plan 2011\u20132020","author":"World Health Organization","year":"2013"},{"issue":"203","key":"10.1016\/j.vaccine.2020.03.044_b0190","first-page":"35","article-title":"\u201cWe are the heroes because we are ready to die for this country\u201d: participants' decision-making and grounded ethics in an Ebola vaccine clinical trial","volume":"2018","author":"Tengbeh","year":"1982","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.044_b0195","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12889-016-3799-x","article-title":"Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone","volume":"16","author":"Enria","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.03.044_b0200","unstructured":"World Health Organization. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response; 2019 [cited 2019 November]. Available from: https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-ring-vaccination-results-12-april-2019.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.03.044_b0205","unstructured":"World Health Organization. A research and development Blueprint for action to prevent epidemics; 2020. Available from: https:\/\/www.who.int\/blueprint\/about\/en\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:01Z","timestamp":1759401781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304230"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}